These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6361701)

  • 21. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
    Tselentis J; Legakis NJ; Nicolas KJ; Melissinos K; Papavassiliou J
    Chemotherapy; 1980; 26(6):409-17. PubMed ID: 7408554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of gentamicin and netilmicin in the treatment of gram-negative infections.
    LeFrock JL; Carr BB; Blias F; Schell RF; Dematteo C; Tillotson JR
    Drug Intell Clin Pharm; 1985 Apr; 19(4):309-15. PubMed ID: 3891278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.
    Miller GH; Arcieri G; Weinstein MJ; Waitz JA
    Antimicrob Agents Chemother; 1976 Nov; 10(5):827-36. PubMed ID: 1008541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.
    Lerner AM; Reyes MP; Cone LA; Blair DC; Jansen W; Wright GE; Lorber RR
    Lancet; 1983 May; 1(8334):1123-6. PubMed ID: 6133153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin.
    Cone LA
    Clin Ther; 1982; 5(2):155-62. PubMed ID: 6760967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.
    Bock BV; Edelstein PH; Meyer RD
    Antimicrob Agents Chemother; 1980 Feb; 17(2):217-25. PubMed ID: 6992711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Netilmicin versus tobramycin in multi-centre studies.
    Daschner FD; Just HM; Jansen W; Lorber R
    J Antimicrob Chemother; 1984 Jan; 13 Suppl A():37-45. PubMed ID: 6365881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aminoglycoside antibiotics from a clinical viewpoint].
    Lüthy R
    Schweiz Med Wochenschr; 1976 Mar; 106(13):450-5. PubMed ID: 1265459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminoglycoside resistance patterns in Turkey.
    Akalin HE; Torun M; Alacam R
    Scand J Infect Dis; 1988; 20(2):199-203. PubMed ID: 2840733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
    Olier B; Morin JP; Thomas N; Fillastre JP
    Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982.
    Kahlmeter G; Dahlager JI
    J Antimicrob Chemother; 1984 Jan; 13 Suppl A():9-22. PubMed ID: 6365884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods].
    Jakoniuk P; Wieczorek P; Sacha PT; Zalewska M; Leszczyńska K
    Med Dosw Mikrobiol; 2006; 58(4):363-70. PubMed ID: 17642314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of resistance to netilmicin and other aminoglycosides.
    Toscano MA; Russo G; Nicoletti G; Stefani S; Geraci C; Alessandria E
    Chemioterapia; 1986 Jun; 5(3):191-5. PubMed ID: 3719853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative ototoxicity of netilmicin, gentamicin, and tobramycin in cats.
    McCormick GC; Weinberg E; Szot RJ; Schwartz E
    Toxicol Appl Pharmacol; 1985 Mar; 77(3):479-89. PubMed ID: 3975915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Netilmicin in gram-negative bacterial infections.
    Snydman DR; Tally FP; Landesman SH; Barza M; Gorbach SL
    Antimicrob Agents Chemother; 1979 Jan; 15(1):50-4. PubMed ID: 426506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.